Olema Pharmaceuticals Cash Flow Statement
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.820.00 (0.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Olema Pharmaceuticals free cash flow
In fiscal 2025, Olema Pharmaceuticals generated -$146.7 million of operating cash flow. That left free cash flow of -$146.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Olema Pharmaceuticals cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -162.45M | -129.47M | -96.66M | -104.79M | -71.10M | -22.12M | -4.32M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| Depreciation & Amortization | 490.00K | 393.00K | 377.00K | 357.00K | 163.00K | 11.00K | 9.00K |
| Stock-Based Compensation | 17.59M | 22.58M | 17.26M | 18.83M | 15.91M | 3.11M | — |
| Change in Working Capital | -820.00K | 2.08M | 3.02M | -763.00K | -713.00K | -727.00K | 868.00K |
| Operating Cash Flow | -146.72M | -104.35M | -83.73M | -82.06M | -50.69M | -19.87M | -3.08M |
| Capital Expenditures | — | -159.00K | — | -363.00K | -1.57M | -56.00K | — |
| Investing Cash Flow | -155.76M | -93.53M | -4.85M | 91.48M | -275.44M | -56.00K | — |
| Financing Cash Flow | 211.30M | 268.82M | 133.41M | 476.00K | 1.39M | 358.40M | — |
| Net Change in Cash | -91.18M | 70.94M | 44.84M | 9.89M | -324.74M | 338.48M | -3.08M |
| Free Cash Flow | -146.72M | -104.51M | -83.73M | -82.43M | -52.27M | -19.92M | -3.08M |
This table shows 7 annual periods of Olema Pharmaceuticals's cash flow statement, from FY 2025 back to FY 2019, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OLMA's reporting calendar. What is a cash flow statement?